Abstract
Introduction
Sympathetic nervous system hyperactivity is common after subarachnoid hemorrhage (SAH). We sought to determine whether uncontrolled prolonged heart rate elevation is a risk factor for adverse cardiopulmonary events and poor outcome after SAH.
Methods
We prospectively studied 447 SAH patients between March 2006 and April 2012. Prior studies define prolonged elevated heart rate (PEHR) as heart rate >95 beats/min for >12 h. Major adverse cardiopulmonary events were documented according to the predefined criteria. Global outcome at 3 months was assessed with the modified Rankin Scale (mRS).
Results
175 (39 %) patients experienced PEHR. Nonwhite race/ethnicity, admission Hunt–Hess grade ≥4, elevated APACHE-2 physiological subscore, and modified Fisher score were significant admission predictors of PEHR, whereas documented pre-hospital beta-blocker use was protective. After controlling for admission Hunt–Hess grade, Cox regression using time-lagged covariates revealed that PEHR onset in the previous 48 h was associated with an increased hazard for delayed cerebral ischemia, myocardial injury, and pulmonary edema. PEHR was associated with 3-month poor outcome (mRS 4–6) after controlling for known predictors.
Conclusions
PEHR is associated with major adverse cardiopulmonary events and poor outcome after SAH. Further study is warranted to determine if early sympatholytic therapy targeted at sustained heart rate control can improve outcome after SAH.
Similar content being viewed by others
References
Cruickshank J, Neil-Dwyer G, Stott A. Possible role of catecholamines, corticosteroids, and potassium in production of electrocardiographic abnormalities associated with subarachnoid haemorrhage. Br Heart J. 1974;36:697.
Dilraj A, Botha JH, Rambiritch V, Miller R, van Dellen JR. Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery. 1992;31:42.
Grad A, Kiauta T, Osredkar J. Effect of elevated plasma norepinephrine on electrocardiographic changes in subarachnoid hemorrhage. Stroke. 1991;22:746–9.
Naredi S, Lambert G, Eden E, et al. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke. 2000;31:901–6.
Cruickshank J, Neil-Dwyer G, Lane J. The effect of oral propranolol upon the ECG changes occurring in subarachnoid haemorrhage. Cardiovasc Res. 1975;9:236–45.
Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112:2851.
Temes RE, Schmidt JM, Naidech AM, et al. Association of severe left ventricular dysfunction after SAH with stroke from delayed vasospasm and functional outcome among patients. In: 3rd annual meeting of the neurocritical care society (platform presentation). Pheonix: Neurocrit Care; 2005 p. 2.
Muroi C, Keller M, Pangalu A, Fortunati M, Yonekawa Y, Keller E. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20:188–92.
Frontera JA, Parra A, Shimbo D, et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis. 2008;26:71–8.
Banki NM, Kopelnik A, Dae MW, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314–9.
Brouwers PJ, Westenberg H, Van Gijn J. Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1995;58:614–7.
Crago E, Kerr M, Kong Y, et al. The impact of cardiac complications on outcome in the SAH population. Acta Neurol Scand. 2004;110:248–53.
Mayer S, Fink M, Homma S, et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology. 1994;44:815.
Sander O, Welters ID, Foëx P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications*. Crit Care Med. 2005;33:81.
Auerbach AD, Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery. JAMA. 2002;287:1435–44.
Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:994–1025.
Komotar R, Schmidt J, Starke R, et al. Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery. 2009;64:397.
Wartenberg KE, Schmidt JM, Temes RE, et al. Medical complications after subarachnoid hemorrhage: frequency and impact on outcome. Stroke. 2005;36:521.
Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012–20.
de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin ‘handicap’ grades after stroke. Stroke. 1995;26:2027–30.
Scharfstein S, Neaton J, Hogan J, et al. Minimal standards in the prevention and handling of missing data in observational and experimental patient centered outcomes research. Washington, DC: Patient-Centered Outcomes Research Institute; 2012.
Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1994.
Su YS, Gelman A, Hill J, Yajima M. Multiple imputation with diagnostics (mi) in R: opening windows into the black box. J Stat Softw. 2011;45:1–31.
Landesberg G, Luria M, Cotev S, et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. The Lancet. 1993;341:715–9.
Dhar R. Diringer MN. Neurocrit Care: The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage; 2008.
Neil-Dwyer G, Walter P, Cruickshank J, Stratton C. Beta-blockade in subarachnoid haemorrhage. Drugs. 1983;25(Suppl 2):273–7.
Neil-Dwyer G, Walter P, Cruickshank J. β-Blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol. 1985;28:25–9.
Cotton BA, Snodgrass KB, Fleming SB, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma Acute Care Surg. 2007;62:26–35.
Coghlan LA, Hindman BJ, Bayman EO, et al. Independent associations between electrocardiographic abnormalities and outcomes in patients with aneurysmal subarachnoid hemorrhage findings from the intraoperative hypothermia aneurysm surgery trial. Stroke. 2009;40:412–8.
Mayer SA, Kurtz P, Wyman A, et al. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the studying the treatment of acute hypertension registry. Crit Care Med. 2011;39:2330–6.
Naredi S, Lambert G, Friberg P, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med. 2006;32:1955–61.
Schmidt HB, Werdan K, Müller-Werdan U. Autonomic dysfunction in the ICU patient. Cur opin crit care. 2001;7:314–22.
Acknowledgments
The project described was supported in part by a research grant from Baxter Healthcare™. The sponsors had no involvement in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. Additional support was provided by the Charles A. Dana Foundation (SAM) and by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number KL2 TR000081, formerly the National Center for Research Resources, Grant Number KL2 RR024157 (JMS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmidt, J.M., Crimmins, M., Lantigua, H. et al. Prolonged Elevated Heart Rate is a Risk Factor for Adverse Cardiac Events and Poor Outcome after Subarachnoid Hemorrhage. Neurocrit Care 20, 390–398 (2014). https://doi.org/10.1007/s12028-013-9909-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-013-9909-z